Industry: Service & Software
Published Date: 2026-07-14
Pages: 113 Pages
Report ld: 6915073
Request Sample
Customized Report
The global market for Artificial Intelligence in Diagnostics was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report provides a comprehensive view of the global market for Artificial Intelligence in Diagnostics, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Artificial Intelligence in Diagnostics market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Diagnostics.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Artificial Intelligence in Diagnostics companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Artificial Intelligence in Diagnostics revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Artificial Intelligence in Diagnostics revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Artificial Intelligence in Diagnostics Product Introduction
1.2 Global Artificial Intelligence in Diagnostics Market Size Forecast (2021–2032)
1.3 Artificial Intelligence in Diagnostics Market Trends & Drivers
1.3.1 Artificial Intelligence in Diagnostics Industry Trends
1.3.2 Artificial Intelligence in Diagnostics Market Drivers & Opportunities
1.3.3 Artificial Intelligence in Diagnostics Market Challenges
1.3.4 Artificial Intelligence in Diagnostics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Artificial Intelligence in Diagnostics Players Revenue Ranking (2025)
2.2 Global Artificial Intelligence in Diagnostics Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Artificial Intelligence in Diagnostics Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Artificial Intelligence in Diagnostics
2.6 Artificial Intelligence in Diagnostics Market Competitive Analysis
2.6.1 Artificial Intelligence in Diagnostics Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Artificial Intelligence in Diagnostics Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Artificial Intelligence in Diagnostics revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Artificial Intelligence in Diagnostics Market Classification
3.1 Introduction by Type
3.1.1 Software
3.1.2 Hardware
3.1.3 Services
3.1.4 Global Artificial Intelligence in Diagnostics Sales Value by Type
3.1.4.1 Global Artificial Intelligence in Diagnostics Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Artificial Intelligence in Diagnostics Sales Value, by Type (2021–2032)
3.1.4.3 Global Artificial Intelligence in Diagnostics Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cardiology
4.1.2 Oncology
4.1.3 Pathology
4.1.4 Radiology
4.1.5 Chest and Lung
4.1.6 Neurology
4.1.7 Others
4.2 Global Artificial Intelligence in Diagnostics Sales Value by Application
4.2.1 Global Artificial Intelligence in Diagnostics Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Artificial Intelligence in Diagnostics Sales Value by Application (2021–2032)
4.2.3 Global Artificial Intelligence in Diagnostics Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Artificial Intelligence in Diagnostics Sales Value by Region
5.1.1 Global Artificial Intelligence in Diagnostics Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Artificial Intelligence in Diagnostics Sales Value by Region (2021–2026)
5.1.3 Global Artificial Intelligence in Diagnostics Sales Value by Region (2027–2032)
5.1.4 Global Artificial Intelligence in Diagnostics Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Artificial Intelligence in Diagnostics Sales Value, 2021–2032
5.2.2 North America Artificial Intelligence in Diagnostics Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Artificial Intelligence in Diagnostics Sales Value, 2021–2032
5.3.2 Europe Artificial Intelligence in Diagnostics Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Artificial Intelligence in Diagnostics Sales Value, 2021–2032
5.4.2 Asia Pacific Artificial Intelligence in Diagnostics Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Artificial Intelligence in Diagnostics Sales Value, 2021–2032
5.5.2 South America Artificial Intelligence in Diagnostics Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Artificial Intelligence in Diagnostics Sales Value, 2021–2032
5.6.2 Middle East & Africa Artificial Intelligence in Diagnostics Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Artificial Intelligence in Diagnostics Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Artificial Intelligence in Diagnostics Sales Value, 2021–2032
6.3 United States
6.3.1 United States Artificial Intelligence in Diagnostics Sales Value, 2021–2032
6.3.2 United States Artificial Intelligence in Diagnostics Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Artificial Intelligence in Diagnostics Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Artificial Intelligence in Diagnostics Sales Value, 2021–2032
6.4.2 Europe Artificial Intelligence in Diagnostics Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Artificial Intelligence in Diagnostics Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Artificial Intelligence in Diagnostics Sales Value, 2021–2032
6.5.2 China Artificial Intelligence in Diagnostics Sales Value by Type (%), 2025 vs 2032
6.5.3 China Artificial Intelligence in Diagnostics Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Artificial Intelligence in Diagnostics Sales Value, 2021–2032
6.6.2 Japan Artificial Intelligence in Diagnostics Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Artificial Intelligence in Diagnostics Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Artificial Intelligence in Diagnostics Sales Value, 2021–2032
6.7.2 South Korea Artificial Intelligence in Diagnostics Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Artificial Intelligence in Diagnostics Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Artificial Intelligence in Diagnostics Sales Value, 2021–2032
6.8.2 Southeast Asia Artificial Intelligence in Diagnostics Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Artificial Intelligence in Diagnostics Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Artificial Intelligence in Diagnostics Sales Value, 2021–2032
6.9.2 India Artificial Intelligence in Diagnostics Sales Value by Type (%), 2025 vs 2032
6.9.3 India Artificial Intelligence in Diagnostics Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Aidoc Medical
7.1.1 Aidoc Medical Profile
7.1.2 Aidoc Medical Main Business
7.1.3 Aidoc Medical Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.1.4 Aidoc Medical Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.1.5 Aidoc Medical Recent Developments
7.2 AliveCor
7.2.1 AliveCor Profile
7.2.2 AliveCor Main Business
7.2.3 AliveCor Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.2.4 AliveCor Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.2.5 AliveCor Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Profile
7.3.2 GE Healthcare Main Business
7.3.3 GE Healthcare Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.3.4 GE Healthcare Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.3.5 GE Healthcare Recent Developments
7.4 Siemens Healthineers AG
7.4.1 Siemens Healthineers AG Profile
7.4.2 Siemens Healthineers AG Main Business
7.4.3 Siemens Healthineers AG Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.4.4 Siemens Healthineers AG Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.4.5 Siemens Healthineers AG Recent Developments
7.5 Imagen Technologies,Inc
7.5.1 Imagen Technologies,Inc Profile
7.5.2 Imagen Technologies,Inc Main Business
7.5.3 Imagen Technologies,Inc Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.5.4 Imagen Technologies,Inc Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.5.5 Imagen Technologies,Inc Recent Developments
7.6 Vuno Inc
7.6.1 Vuno Inc Profile
7.6.2 Vuno Inc Main Business
7.6.3 Vuno Inc Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.6.4 Vuno Inc Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.6.5 Vuno Inc Recent Developments
7.7 IDx Technologies Inc
7.7.1 IDx Technologies Inc Profile
7.7.2 IDx Technologies Inc Main Business
7.7.3 IDx Technologies Inc Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.7.4 IDx Technologies Inc Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.7.5 IDx Technologies Inc Recent Developments
7.8 NovaSignal Corporation
7.8.1 NovaSignal Corporation Profile
7.8.2 NovaSignal Corporation Main Business
7.8.3 NovaSignal Corporation Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.8.4 NovaSignal Corporation Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.8.5 NovaSignal Corporation Recent Developments
7.9 Riverain Technologies
7.9.1 Riverain Technologies Profile
7.9.2 Riverain Technologies Main Business
7.9.3 Riverain Technologies Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.9.4 Riverain Technologies Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.9.5 Riverain Technologies Recent Developments
7.10 Zebra Medical Vision
7.10.1 Zebra Medical Vision Profile
7.10.2 Zebra Medical Vision Main Business
7.10.3 Zebra Medical Vision Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.10.4 Zebra Medical Vision Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.10.5 Zebra Medical Vision Recent Developments
7.11 OSPLabs
7.11.1 OSPLabs Profile
7.11.2 OSPLabs Main Business
7.11.3 OSPLabs Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.11.4 OSPLabs Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.11.5 OSPLabs Recent Developments
7.12 Philips
7.12.1 Philips Profile
7.12.2 Philips Main Business
7.12.3 Philips Artificial Intelligence in Diagnostics Products, Services, and Solutions
7.12.4 Philips Artificial Intelligence in Diagnostics Revenue (US$ Million), 2021–2026
7.12.5 Philips Recent Developments
8 Industry Chain Analysis
8.1 Artificial Intelligence in Diagnostics Value Chain
8.2 Artificial Intelligence in Diagnostics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Artificial Intelligence in Diagnostics Sales Model
8.5.2 Sales Channels
8.5.3 Artificial Intelligence in Diagnostics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Artificial Intelligence in Diagnostics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 119
USD 2900.00
(Single User License)
The global Artificial Intelligence in Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 137
USD 4900.00
(Single User License)
The global Artificial Intelligence in Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 94
USD 4250.00
(Single User License)
The global market for Artificial Intelligence in Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 111
USD 3950.00
(Single User License)
The global market for Artificial Intelligence in Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 89
USD 2900.00
(Single User License)
The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
Published Date: 2024-04-25
Pages: 106
USD 4900.00
(Single User License)
The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
Published Date: 2024-02-22
Pages: 106
USD 3950.00
(Single User License)
The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
Published Date: 2024-02-06
Pages: 88
USD 2900.00
(Single User License)
The global Artificial Intelligence in Diagnostics market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 119
The global Artificial Intelligence in Diagnostics market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 137
The global Artificial Intelligence in Diagnostics market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 94
The global market for Artificial Intelligence in Diagnostics was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 111
The global market for Artificial Intelligence in Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 89
The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
Published: 2024-04-25
Pages: 106
The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
Published: 2024-02-22
Pages: 106
The implementation of artificial intelligence (AI) technology in medical diagnostic devices and systems has changed the way patients are treated and diagnosed in the healthcare industry.Artificial intelligence is mainly used in medical institutions to check the correlation between treatment procedures and patient prognosis.After successful deployment and success, AI technology is likely to be widely used in medical practice, including medical imaging, drug development, personalized medicine and patient monitoring and care.The use of AI technology and machine learning in diagnostics can strengthen the growth of the global market by improving patient safety to improve diagnostic accuracy and reduce costs.
Published: 2024-02-06
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now